---
figid: PMC5406893__13073_2017_429_Fig7_HTML
figlink: /pmc/articles/PMC5406893/figure/Fig7/
number: F7
caption: Summary of the survival and growth phenotypes in breast cancer. The survival
  phenotype is characterized by high HER2, IGF1R, and AKT pathway activation, high
  expression of pro-apoptotic BIM, low expression of anti-apoptotic MCL-1, and response
  to HER2, AKT, PI3K, and mTOR inhibitors. The growth phenotype is characterized by
  high EGFR, KRAS, and RAF1 activation, high expression of MCL-1, low expression of
  BIM, and response to EGFR/MEK-targeted therapies and chemotherapies
pmcid: PMC5406893
papertitle: Activity of distinct growth factor receptor network components in breast
  tumors uncovers two biologically relevant subtypes.
reftext: Mumtahena Rahman, et al. Genome Med. 2017;9:40.
pmc_ranked_result_index: '20832'
pathway_score: 0.9302001
filename: 13073_2017_429_Fig7_HTML.jpg
figtitle: Summary of the survival and growth phenotypes in breast cancer
year: '2017'
organisms: Homo sapiens
ndex: 02c69efc-dea6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5406893__13073_2017_429_Fig7_HTML.html
  '@type': Dataset
  description: Summary of the survival and growth phenotypes in breast cancer. The
    survival phenotype is characterized by high HER2, IGF1R, and AKT pathway activation,
    high expression of pro-apoptotic BIM, low expression of anti-apoptotic MCL-1,
    and response to HER2, AKT, PI3K, and mTOR inhibitors. The growth phenotype is
    characterized by high EGFR, KRAS, and RAF1 activation, high expression of MCL-1,
    low expression of BIM, and response to EGFR/MEK-targeted therapies and chemotherapies
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - KRAS
  - MCL1
  - PIK3R4
  - PIK3CD
  - PIK3CB
  - AKT2
  - ERBB2
  - PIK3CA
  - PIK3R6
  - PIK3R5
  - BCL2L11
  - RAF1
  - AKT3
  - AKT1
  - PIK3CG
  - EGFR
  - BAD
  - MTOR
  - PIK3R3
  - MAP2K1
  - MAP2K2
  - Cancer
  - Lung cancer
genes:
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MCL1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: BIM
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: RAF1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: HER2/AKT/PI3K/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HER2/AKT/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: EGFR/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: EGFR/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC5406893__F7
redirect_from: /figures/PMC5406893__F7
figtype: Figure
---
